In patients with moderate- and high-risk acute coronary syndromes (ACS) undergoing percutaneous coronary intervention (PCI), the Syntax score predicts 1-year ischemic outcomes including mortality, ...
The 3-year results of the SYNTAX trial, according to data presented by Patrick W. Serruys, MD, PhD, suggested that percutaneous coronary intervention is a reasonable alternative to CABG for patients ...
The extent and severity of disease, as assessed by Syntax score, strongly correlates with the risk of stent thrombosis at 30 days and 1 year in patients with non-ST-segment elevation acute coronary ...
September 13, 2010 (Geneva, Switzerland) — Three-year results for the landmark SYNTAX trial are bringing some clarity to a finding just hinted at--then strenuously debated--at the two-year mark: ...
Please provide your email address to receive an email when new articles are posted on . At 5 years, elevated rates of major CV events were found in patients with diabetes and stable ischemic heart ...
Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window PARIS -- With ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback